Validated for tumorsphere formations from a variety of human tumor origins, including, but not limited to, breast adenocarcinoma (MCF-7), cervical carcinoma (HeLa) and alveolar adenocarcinoma (A549)
Contains BSA
Manufactured under cGMP conditions
Available in 100mL packaging
Custom packaging available
For research or further manufacturing use only.
Contact us for international pricing.
存储:
This product is shipped with dry ice. Upon receipt, store the medium at or below -10°C in a manual defrost freezer.
Supports robust induction of adipogenesis from human mesenchymal stem/stromal cells (MSCs)
Classical staining method and immunocytochemistry demonstrate the presence of adipocytes
Manufactured under cGMP conditions
Available as 100 mL complete, ready-to-use medium
Custom packaging available
For research or further manufacturing use only.
Contact us for international pricing.
Storage
This product is shipped with dry ice. Upon receipt, store the medium at or below -10°C in a manual defrost freezer.
Shelf Life
Handle using aseptic techniques to avoid contamination. Unopened liquid medium is stable for 30 months from date of manufacture, as indicated on the label.
PRIME-XV Neural Basal Medium is a chemically-defined, animal component-free medium that supports a range of applications for neural stem cells.
Generation and expansion of iPSC-derived NPCs
Generate and expand neural progenitors from iPSCs or ESCs while maintaining their multipotency.
Long-term neuronal culture
PRIME-XV Neural Basal Medium used with PRIME-XV IS21 neural supplement provides a complete optimized solution for neuronal culture maintaining viability and morphology, and minimizing glial contamination. PRIME-XV products are optimized for efficacy and consistency in neural culture thereby eliminating the time-consuming tests of neural supplements.
Achieve greater expansion of NPCs compared to other available media
Achieve higher cell density and confluency while maintaining multipotency, marker expression profiles and morphology.
Maintain viability, morphology and marker expression in long term neuronal cultures
Rat hippocampal neurons cultured in PRIME-XV Neural Basal Medium/PRIME-XV IS21 Supplement for 14 days. Positive expression of neuron marker MAP2 and negative astrocyte marker GFAP show maintenance of neurons.
Storage
This product is shipped at 2-8°C with cold packs. Upon receipt, store immediately at 2-8°C and protect from light.
Chemically defined, animal component-free medium for natural killer (NK) and NKT cell expansion optimized to deliver cell growth while maintaining NK and NKT cell functionality and potency.
Details
PRIME-XV NK Cell CDM is the first commercial chemically defined animal component-free medium for the ex vivo expansion of natural killer cells.
Designed for use in NK and NKT cell-based immunotherapy research and translational applications, this advanced formulation delivers growth while maintaining NK and NKT cell functionality and potency—without the need for serum supplementation.
Key benefits include:
Efficient ex vivo expansion of NK and NKT cells in a chemically defined medium (CDM) designed to deliver high lot-to-lot consistency
Animal component-free (ACF) formulation helps to minimize the risk from adventitious agents
Formulated to support NK and NKT cells derived from peripheral blood mononuclear cells (PBMCs)
Designed to facilitate a seamless transition from the laboratory to further manufacturing use:
cGMP manufactured for quality, consistency, and scalability
Robust raw material controls and supply chain management
Traceability documentation provided, including Certificates of Analysis, Certificates of Origin, and a Drug Master File (DMF)† filed with the U.S. FDA
Extensive QC testing, including functionality, sterility, and endotoxin
Mycoplasma USP <63> testing is standard on all lots
Custom sizes and packaging available on request
† DMF filing pending.
Improved NK Cell Expansion in Chemically-defined Conditions
Storage
This product is shipped at 2-8°C with cold packs. Upon receipt, store immediately at 2-8°C and protect from light.
Shelf Life
Unopened liquid medium is stable for 18 months from date of manufacture, as indicated on the label, when stored at 2-8°C and protected from light. Once opened, the product should be stored at 2-8°C in the dark and used within 4 weeks.
Offering the ability to scale-up to various automated bioreactors with increased speed for T cell culture, PRIME-XV T Cell CDM is fully optimized for immune therapy and research. Chemically defined and animal component-free, it delivers consistent growth while maintaining T cell functionality and potency in scalable therapy or research.
Details
PRIME-XV T Cell CDM is the first commercially available chemically defined, animal component-free medium for the expansion and cultivation of human T cells. The performance and functionality of PRIME-XV T Cell CDM continues to set the standard as the application process becomes more dynamic and closed.
Provides optimal performance:
Supports vigorous T cell growth in static and dynamic automation systems while maintaining functionality
Provides lot-to-lot consistency for reliable formulation composition
Removes the effects of undefined components to minimize unwarranted T cell phenotypes
Supports polarization to targeted T cell types such as Th1 and T regulatory cells to further possible therapy applications
Manufactured to facilitate transfer from research to clinic:
Chemically defined, animal component-free formula minimizes risks from adventitious agents
Manufactured in compliance with cGMP regulations
Traceability documentation provided including Certificates of Analysis, Certificates of Origin, and a Drug Master File (DMF) filed with the US FDA
Extensive QC testing including functionality, sterility, and endotoxin
Mycoplasma USP <63> testing is standard on all lots
Custom formulation, sizes and packaging available for all commercially available automation systems
PRIME-XV T Cell CDM supports viable T cell expansion across different culture vessels
Figure 1: (A) Fold expansion of CD3+ cells in PRIME-XV T Cell CDM is robust across the three documented culture systems, performing as well as or better than FBS-supplemented RPMI and commercially available XSF media. (B) Viability is maintained at or above 85% by the end of the culture period in all three cell culture systems. Though significant inter-donor variability is observed, these data are representative of three donors, analyzed on day 14 (plates, flasks and G-Rex) or day 9 (Quantum bioreactors).
Publication, presentation, and protocol available for download
Protocols support G-Rex and Quantum
Protocols for plates and flasks can be provided
Storage
This product is shipped at 2-8°C with cold packs. Upon receipt, store immediately at 2-8°C and protect from light.
Shelf Life
Handle using aseptic techniques to avoid contamination. Unopened liquid medium is stable for 24 months from date of manufacture, as indicated on the label.
Offering the ability to scale-up to various automated bioreactors with increased speed for T cell culture, PRIME-XV T Cell CDM is fully optimized for immune therapy and research. Chemically defined and animal component-free, it delivers consistent growth while maintaining T cell functionality and potency in scalable therapy or research.
PRIME-XV T Cell CDM is the first commercially available chemically defined, animal component-free medium for the expansion and cultivation of human T cells. The performance and functionality of PRIME-XV T Cell CDM continues to set the standard as the application process becomes more dynamic and closed.
PRIME-XV T细胞CDM是第一个商业上可用的化学定义的,无动物成分的培养基,用于扩增和培养人类T细胞。随着应用过程变得更加动态和封闭,PRIME-XV T Cell CDM的性能和功能继续设定标准。
Provides optimal performance:
Supports vigorous T cell growth in static and dynamic automation systems while maintaining functionality
Provides lot-to-lot consistency for reliable formulation composition
Removes the effects of undefined components to minimize unwarranted T cell phenotypes
Supports polarization to targeted T cell types such as Th1 and T regulatory cells to further possible therapy applications
Manufactured to facilitate transfer from research to clinic:
Chemically defined, animal component-free formula minimizes risks from adventitious agents
Manufactured in compliance with cGMP regulations
Traceability documentation provided including Certificates of Analysis, Certificates of Origin, and a Drug Master File (DMF) filed with the US FDA
Extensive QC testing including functionality, sterility, and endotoxin
Mycoplasma USP <63> testing is standard on all lots
Custom formulation, sizes and packaging available for all commercially available automation systems
PRIME-XV T Cell CDM supports viable T cell expansion across different culture vessels
Figure 1: (A) Fold expansion of CD3+ cells in PRIME-XV T Cell CDM is robust across the three documented culture systems, performing as well as or better than FBS-supplemented RPMI and commercially available XSF media. (B) Viability is maintained at or above 85% by the end of the culture period in all three cell culture systems. Though significant inter-donor variability is observed, these data are representative of three donors, analyzed on day 14 (plates, flasks and G-Rex) or day 9 (Quantum bioreactors).
Publication, presentation, and protocol available for download
Protocols support G-Rex and Quantum
Protocols for plates and flasks can be provided
存储:
This product is shipped at 2-8°C with cold packs. Upon receipt, store immediately at 2-8°C and protect from light.
保质期:
Handle using aseptic techniques to avoid contamination. Unopened liquid medium is stable for 24 months from date of manufacture, as indicated on the label.